Lepik & Luhaäär; Kļaviņš & Slaidiņš; Lideika, Petrauskas, Valiūnas ir partneriai

Cambrex Corporation acquires an Estonian pharmaceuticals and development company, AS ProSyntest

Advising Cambrex Corporation, a leading producer of pharmaceutical products listed on the New York Stock Exchange, in the acquisition of an Estonian pharmaceuticals and development company AS ProSyntest.

Search news

All practices

Experience Highlights archive